Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaФаза 2NCT07685717
Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
265 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma265 studies
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaФаза 2NCT07685717
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography
Follicular LymphomaФаза 2NCT06350318
Zanubrutinib, Rituximab
Peripheral T Cell LymphomaФаза 2NCT06630091
Golidocitinib, Cyclophosphamide, Doxorubicin, Vincristine
Hematological MalignanciesФаза 2NCT04634552Papers
Talquetamab
Multiple MyelomaФаза 2NCT07149857
Cilta-cel, Cyclophosphamide, Induction therapy, Fludarabine
Follicular LymphomaФаза 2NCT06563596
Zanubrutinib, Rituximab, Epcoritamab
Recurrent Acute Myeloid LeukemiaФаза 2NCT03629171Papers
Liposome-encapsulated Daunorubicin-Cytarabine, Venetoclax
Large B-cell LymphomaФаза 2NCT06045247
Prednisone, Rituximab, Cyclophosphamide, Vincristine
B-Cell Lymphoblastic LeukemiaФаза 2NCT06144606
Tecartus
B Cell LymphomaФаза 2NCT06213311
Glofitamab, Obinutuzumab, Axi-cel
Relapsed or Refractory Post-Transplant Lymphoproliferative DisorderPhase 1NCT06672705
Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders
Relapsed/Refractory Acute Myeloid LeukemiaPhase 1NCT03874052Papers
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Multiple MyelomaФаза 2NCT05789303
Belantamab mafodotin, Carfilzomib, Pomalidomide, Dexamethasone
Relapsed Classic Hodgkin LymphomaФаза 2NCT04561206
Brentuximab Vedotin, Nivolumab
Relapsed or Refractory Acute Myeloid LeukemiaPhase 1NCT07661095
CRD3874-SI in People With Leukemia
Recurrent Grade 1 Follicular LymphomaФаза 2NCT06453044
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Mosunetuzumab
Lymphoma, Non-HodgkinФаза 2NCT02693535Papers
Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT)
Multiple MyelomaФаза 2NCT04661137Papers
Selinexor 60 MG, Selinexor 80 MG, Selinexor 100 MG, Carfilzomib
Multiple Myeloma RefractoryФаза 2NCT07096778
Inobrodib, Pomalidomide, Dexamethasone
Relapsed / Refractory AMLФаза 2NCT07710534
Decitabine-cedazuridine plus venetoclax (DEC-C+VEN), Azacitidine plus venetoclax (AZA+VEN)
Marginal Zone LymphomaФаза 2NCT05296070
Loncastuximab tesirine 150 µg/Kg, Loncastuximab tesirine 75µg/Kg
Mantle Cell LymphomaPhase 1/2NCT06029309
Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma
T-cell Acute Lymphoblastic LeukemiaФаза 2NCT06561074
Decitabine, Venetoclax, Calaspargase pegol-mknl
Hodgkin LymphomaФаза 2NCT05615636Papers
Mosunetuzumab, Polatuzumab vedotin, Tafasitamab, Lenalidomide